Search Results 861-870 of 6691 for albumin

  1. Oncology (Medical) - Overview - Mayo Clinic

    Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.

  2. Hematology - Clinical trials

    Proton beam radiation therapy is one of the treatments for men with prostate cancer who have localized disease. The benefit of the combination with androgen ...

  3. Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial) - Mayo Clinic

    * Albumin * Glucose * Fibrinogen * Participants must have adequate kidney function as evidenced by creatinine clearance \>= 30mL/min (by Cockcroft Gault) ...

  4. Digestive Diseases Clinical Trials - Medical Professionals

    The standard treatment for locally advanced rectal cancer involves chemotherapy and radiation, known as 5FUCMT, (the chemotherapy drugs ...

  5. A Study of Seladelpar in Subjects with Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA) - Mayo Clinic

    Advanced PBC as defined by the Rotterdam criteria (albumin below LLN AND total bilirubin above 1 × ULN). Creatine kinase (CK) above 1.0 × ULN. eGFR below 60 ...

  6. Biobank Protocol, Rare Diseases Clinical Research Network

    This study is being done to obtain samples from patients with primary hyperoxaluria, cystinuria, adenine phosphoribosyl transferase (APRT) deficiency, and Dent ...

  7. Impact of Blood Volume on QuantiFERON Test Accuracy - Mayo Clinic

    The purpose of this study is to evaluate whether the volume of whole blood collected in QuantiFERON testing tubes impacts the accuracy of test results.

  8. A Randomized Phase 2 Study of Combination Atezolizumab and CDX-1127 (Varlilumab) With or Without Addition of Cobimetinib in Previously Treated Unresectable Biliary Tract Cancers - Mayo Clinic

    - Albumin >= 3.0 g/dL - Prothrombin time (PT)/activated partial thromboplastin time (aPTT) =< 1.5 x ULN (This applies only to patients who do not receive ...

  9. Study of VS-6766 + Adagrasib in KRAS G12C NSCLC Patients - Mayo Clinic

    Albumin ≥3.0 g/dL (451 μmol/L);; Creatine phosphokinase (CPK) ≤ 2.5 x ULN;; Adequate cardiac function with left ventricular ejection fraction ≥ 50% by ...

  10. Clinical trials - Hematology

    Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the growth ...